- Home
- NDLS vs ANVS Comparison
NDLS vs ANVS Comparison
Compare NDLS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- ANVS
- Stock Information
- Founded
- NDLS 1995
- ANVS 2008
- Country
- NDLS United States
- ANVS United States
- Employees
- NDLS N/A
- ANVS N/A
- Industry
- NDLS Restaurants
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- NDLS Consumer Discretionary
- ANVS Health Care
- Exchange
- NDLS Nasdaq
- ANVS Nasdaq
- Market Cap
- NDLS 34.3M
- ANVS 31.2M
- IPO Year
- NDLS 2013
- ANVS 2020
- Fundamental
- Price
- NDLS $1.18
- ANVS $1.58
- Analyst Decision
- NDLS Strong Buy
- ANVS Strong Buy
- Analyst Count
- NDLS 2
- ANVS 5
- Target Price
- NDLS $3.00
- ANVS $37.00
- AVG Volume (30 Days)
- NDLS 122.1K
- ANVS 259.9K
- Earning Date
- NDLS 03-06-2025
- ANVS 05-12-2025
- Dividend Yield
- NDLS N/A
- ANVS N/A
- EPS Growth
- NDLS N/A
- ANVS N/A
- EPS
- NDLS N/A
- ANVS N/A
- Revenue
- NDLS $493,271,000.00
- ANVS N/A
- Revenue This Year
- NDLS $4.73
- ANVS N/A
- Revenue Next Year
- NDLS $1.30
- ANVS N/A
- P/E Ratio
- NDLS N/A
- ANVS N/A
- Revenue Growth
- NDLS N/A
- ANVS N/A
- 52 Week Low
- NDLS $0.55
- ANVS $1.43
- 52 Week High
- NDLS $2.36
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- NDLS 48.32
- ANVS 35.70
- Support Level
- NDLS $1.01
- ANVS $1.43
- Resistance Level
- NDLS $1.20
- ANVS $2.07
- Average True Range (ATR)
- NDLS 0.08
- ANVS 0.15
- MACD
- NDLS 0.00
- ANVS 0.04
- Stochastic Oscillator
- NDLS 89.47
- ANVS 23.44
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.